Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels-Balancing Benefits and Risks: Evidence From a Large Community-Based Study
- Increased Risk of Exacerbation and Hospitalization in Subjects With an Overlap Phenotype: COPD-Asthma
- Air Travel: Effects of Sleep Deprivation and Jet Lag
- Efficacy and Safety of Cognitive Enhancers for Patients With Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- Severe Hypoglycaemia and Cardiovascular Disease: Systematic Review and Meta-Analysis With Bias Analysis
- FDA Invites Public Input on Menthol in Cigarettes
- A Review on Drug Interactions and Cytochrome P450
- The Impact of Pharmacist-Directed Patient Education and Anticoagulant Care Coordination on Patient Satisfaction
- Pharmacist-Physician Collaboration for Diabetes Care: The Diabetes Initiative Program
- SSRI Use Associated With Risk of Poor Surgical Outcomes